Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:477454rdf:typepubmed:Citationlld:pubmed
pubmed-article:477454lifeskim:mentionsumls-concept:C0004623lld:lifeskim
pubmed-article:477454lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:477454lifeskim:mentionsumls-concept:C0007546lld:lifeskim
pubmed-article:477454lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:477454lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:477454lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:477454pubmed:issue5lld:pubmed
pubmed-article:477454pubmed:dateCreated1979-11-21lld:pubmed
pubmed-article:477454pubmed:abstractTextCefazolin sodium was used to treat 20 serious bacterial infections in 19 patients, 11 of whom were infected by coagulase-positive Staphylococci. Clinical and bacteriologic success were initially obtained in 15 patients with 16 infections. 2 additional patients were cured after surgery for removal of foreign bodies and a second course of the antibiotic. 1 asplenic patient had bacteremia and died 5 days after initiating therapy with negative blood cultures and multiple abscesses. 1 patient with endocarditis relapsed 19 months after treatment with 6 weeks of cefazolin and prolonged oral antibiotics. Calculated median, trough, free drug levels were 1.5--15.3 times the minimum inhibitory concentration for 27 of 29 pathogens.lld:pubmed
pubmed-article:477454pubmed:languageenglld:pubmed
pubmed-article:477454pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:477454pubmed:citationSubsetIMlld:pubmed
pubmed-article:477454pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:477454pubmed:statusMEDLINElld:pubmed
pubmed-article:477454pubmed:issn0009-3157lld:pubmed
pubmed-article:477454pubmed:authorpubmed-author:FransonT RTRlld:pubmed
pubmed-article:477454pubmed:authorpubmed-author:EdwardsL DLDlld:pubmed
pubmed-article:477454pubmed:authorpubmed-author:CollinsR FRFlld:pubmed
pubmed-article:477454pubmed:authorpubmed-author:RootT ETElld:pubmed
pubmed-article:477454pubmed:issnTypePrintlld:pubmed
pubmed-article:477454pubmed:volume25lld:pubmed
pubmed-article:477454pubmed:ownerNLMlld:pubmed
pubmed-article:477454pubmed:authorsCompleteYlld:pubmed
pubmed-article:477454pubmed:pagination316-25lld:pubmed
pubmed-article:477454pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-H...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-A...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-S...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-F...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-M...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-A...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-M...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-D...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-M...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-D...lld:pubmed
pubmed-article:477454pubmed:meshHeadingpubmed-meshheading:477454-C...lld:pubmed
pubmed-article:477454pubmed:year1979lld:pubmed
pubmed-article:477454pubmed:articleTitleCefazolin treatment of bacterial infections. In vitro and in vivo evaluation.lld:pubmed
pubmed-article:477454pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:477454lld:pubmed